{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:26:38Z","timestamp":1793957198028,"version":"4.8.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019217","name":"AlMaarefa University","doi-asserted-by":"publisher","award":["MHIRSP2025007"],"award-info":[{"award-number":["MHIRSP2025007"]}],"id":[{"id":"10.13039\/100019217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.msard.2026.107893","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:29:14Z","timestamp":1788017354000},"page":"107893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serum neurofilament light chain in multiple sclerosis: promise, pitfalls, and the path to clinical implementation"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2683-4202","authenticated-orcid":false,"given":"Basil Kamal","family":"Alashger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh Nasser","family":"Alnoiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman Hani","family":"Kaltham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abobakr Radfan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany A.","family":"Elkattawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107893_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104662","article-title":"Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis","volume":"93","author":"Bar-Or","year":"2023","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.msard.2026.107893_bib0002","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1093\/brain\/awab241","article-title":"The potential of serum neurofilament as a biomarker for multiple sclerosis","volume":"144","author":"Bittner","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107893_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102807","article-title":"Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study","volume":"56","author":"Bittner","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.msard.2026.107893_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2026.1815022","article-title":"Serum neurofilament light chain in multiple sclerosis: from biological signal to clinically informed decision-making","volume":"17","author":"Caminero","year":"2026","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107893_bib0005","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2026.107893_bib0006","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/acn3.70149","article-title":"Serum neurofilament light chain in multiple sclerosis: superiority of age- and BMI-corrected z scores\/percentiles over absolute cutoff values for prediction of treatment response","volume":"12","author":"Einsiedler","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107893_bib0007","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00415-025-13093-1","article-title":"The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review","volume":"272","author":"Freedman","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107893_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104970","article-title":"Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management","volume":"101","author":"Freedman","year":"2024","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.msard.2026.107893_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.48593","article-title":"Types and concentrations of blood-based biomarkers in adults with peripheral neuropathies: a systematic review and meta-analysis","volume":"5","author":"Fundaun","year":"2022","journal-title":"JAMa Netw. Open."},{"issue":"5","key":"10.1016\/j.msard.2026.107893_bib0010","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/acn3.51355","article-title":"Comparison of Simoa and Ella to assess serum neurofilament-light chain in multiple sclerosis","volume":"8","author":"Gauthier","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2026.107893_bib0011","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/WNL.0000000000010346","article-title":"Serum neurofilament light as a biomarker in progressive multiple sclerosis","volume":"95","author":"Kapoor","year":"2020","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.msard.2026.107893_bib0012","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.msard.2026.107893_bib0013","doi-asserted-by":"crossref","first-page":"e2457","DOI":"10.1212\/WNL.0000000000009571","article-title":"Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis","volume":"94","author":"Manouchehrinia","year":"2020","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2026.107893_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274565","article-title":"Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: a systematic review and meta-analysis","volume":"17","author":"Ning","year":"2022","journal-title":"PLoS. One"},{"issue":"22","key":"10.1016\/j.msard.2026.107893_bib0015","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","article-title":"Monitoring disease activity in multiple sclerosis using serum neurofilament light protein","volume":"89","author":"Novakova","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2026.107893_bib0016","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000749","article-title":"Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis","volume":"7","author":"Reinert","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.msard.2026.107893_bib0017","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/acn3.51060","article-title":"Temporal association of sNfL and gadolinium-enhancing lesions in multiple sclerosis","volume":"7","author":"Rosso","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"23","key":"10.1016\/j.msard.2026.107893_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313153","article-title":"Effect of natalizumab on sNfL and sGFAP levels in multiple sclerosis patients","volume":"25","author":"Sainz-Amo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107893_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2026.107330","article-title":"Is serum neurofilament light chain accurate enough to guide multiple sclerosis care? Diagnostic performance and optimal cutoff in a systematic review and meta-analysis","volume":"112","author":"Santana","year":"2026","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.msard.2026.107893_bib0020","article-title":"Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment-na\u00efve relapsing MS patients","volume":"90","author":"Sejbaek","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107893_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106166","article-title":"Neurofilament light in serum: reference values and effect of risk factors for multiple sclerosis","volume":"92","author":"S\u00f8ndergaard","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2026.107893_bib0022","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/acn3.51704","article-title":"Associations of sNfL with clinico-radiological measures in a large MS population","volume":"10","author":"Sotirchos","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2026.107893_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2026.1743472","article-title":"Serum neurofilament light chain and disease-modifying treatment as predictors of cognitive decline in multiple sclerosis","volume":"17","author":"Taluntiene","year":"2026","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107893_bib0024","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10072-024-07772-6","article-title":"Renal function\u2019s impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysis","volume":"46","author":"Tortosa-Carreres","year":"2025","journal-title":"Neurol. Sci."},{"issue":"13","key":"10.1016\/j.msard.2026.107893_bib0025","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1177\/13524585241277044","article-title":"Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic","volume":"30","author":"Van Lierop","year":"2024","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2026.107893_bib0026","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200045","article-title":"Effect of estimated blood volume and body mass index on GFAP and NfL levels in the serum and CSF of patients with multiple sclerosis","volume":"10","author":"Yalachkov","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107893_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.852563","article-title":"Prognostic value of serum neurofilament light chain for disease activity and worsening in patients with relapsing multiple sclerosis: results from the phase 3 ASCLEPIOS I and II trials","volume":"13","author":"Ziemssen","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2026.107893_bib0028","article-title":"Comparison of Simoa, high-sensitivity ELISA, and CLIA for serum neurofilament light chain quantification in multiple sclerosis","volume":"15","author":"Zondra Revendova","year":"2025","journal-title":"Sci. Rep."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:38:27Z","timestamp":1793954307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826009284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":28,"alternative-id":["S2211034826009284"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107893","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum neurofilament light chain in multiple sclerosis: promise, pitfalls, and the path to clinical implementation","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107893"}}